Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by brad129on Oct 28, 2022 7:23pm
124 Views
Post# 35057180

RE:RE:RE:RE:RE:RE:RE:Trustworthy Much?

RE:RE:RE:RE:RE:RE:RE:Trustworthy Much?

One last thing does it matter if it's Care bringing in the money, Aristotle bringing in the money, combination bringing in the money, or does it really only matter that the company brings in the money makes some cash for them, continue to grow and in turn share price appreciates? I believe I just want to see things moving in an upward projection, for the past couple quarters we have seen movement to the upside in sales, if that continues I will be happy with my money parked here. It will grow if things keep moving in the right direction.


brad129 wrote:

they've tried projections, they've tried "fluff" news they have tried all other ways, maybe they have com to the conclusion the best option is "show me the money" option. Could be right could be wrong,. My purchase the other day says I'm betting on it.



 

Liked2Think wrote: The cycle continues with them.

No concrete info of any kind. 

As time gets closer to results wishfull thinking will take over until the day comes investors are dissapointed as per usual.

 

 

brad129 wrote: Another 2-2.5 weeks we will get some more answers, last quarter they fell just shy of break even, should be hitting that now. No news could be good news, who knows?

 




<< Previous
Bullboard Posts
Next >>